Abstract
On January 23, 2020, China quarantined Wuhan to contain an emerging coronavirus (2019-nCoV). Here, we estimate the probability of 2019-nCoV importations from Wuhan to 369 cities throughout China before the quarantine. The expected risk exceeds 50% in 128 [95% CI 75 186] cities, including five large cities with no reported cases by January 26th.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We acknowledge the financial support from NIH (U01 GM087719), the Investissement d’Avenir program, the Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases program (Grant ANR-10-LABX-62-IBEID) and European Union V.E.O project. None of the authors or their institutions at any time received payment or services from a third party for any aspect of the submitted work.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data will become available upon publication in a peer-reviewed journal.
